image
Healthcare - Medical - Diagnostics & Research - NASDAQ - HK
$ 4.5
7.5 %
$ 55 M
Market Cap
-1.15
P/E
1. INTRINSIC VALUE

This DCF valuation model was last updated on Apr, 22, 2025.

The intrinsic value of one PRE stock under the worst case scenario is HIDDEN Compared to the current market price of 4.5 USD, Prenetics Global Limited is HIDDEN

This DCF valuation model was last updated on Apr, 22, 2025.

The intrinsic value of one PRE stock under the base case scenario is HIDDEN Compared to the current market price of 4.5 USD, Prenetics Global Limited is HIDDEN

This DCF valuation model was last updated on Apr, 22, 2025.

The intrinsic value of one PRE stock under the best case scenario is HIDDEN Compared to the current market price of 4.5 USD, Prenetics Global Limited is HIDDEN

2. FUNDAMENTAL ANALYSIS

Price Chart PRE

image
$6.0$6.0$5.5$5.5$5.0$5.0$4.5$4.5$4.0$4.0$3.5$3.5$3.0$3.0Nov '24Nov '2415 Nov15 NovDec '24Dec '2415 Dec15 DecJan '25Jan '2515 Jan15 JanFeb '25Feb '2515 Feb15 FebMar '25Mar '2515 Mar15 MarApr '25Apr '2515 Apr15 Apr
FINANCIALS
21.7 M REVENUE
-92.12%
-51.9 M OPERATING INCOME
-25.03%
-64.8 M NET INCOME
65.99%
-13.8 M OPERATING CASH FLOW
-94.84%
-83 M INVESTING CASH FLOW
-79.77%
-4.7 M FINANCING CASH FLOW
-3.28%
7.78 M REVENUE
30.91%
-11.8 M OPERATING INCOME
-11.31%
-10.7 M NET INCOME
0.46%
0 OPERATING CASH FLOW
0.00%
0 INVESTING CASH FLOW
0.00%
0 FINANCING CASH FLOW
0.00%
Balance Sheet Prenetics Global Limited
image
Current Assets 93.7 M
Cash & Short-Term Investments 72.7 M
Receivables 5.16 M
Other Current Assets 15.8 M
Non-Current Assets 161 M
Long-Term Investments 108 M
PP&E 5.78 M
Other Non-Current Assets 46.9 M
28.62 %6.20 %42.43 %18.45 %Total Assets$254.2m
Current Liabilities 39.5 M
Accounts Payable 1.67 M
Short-Term Debt 1.5 M
Other Current Liabilities 36.3 M
Non-Current Liabilities 4.53 M
Long-Term Debt 867 K
Other Non-Current Liabilities 3.66 M
3.80 %3.41 %82.50 %8.32 %Total Liabilities$44.0m
EFFICIENCY
Earnings Waterfall Prenetics Global Limited
image
Revenue 21.7 M
Cost Of Revenue 12.9 M
Gross Profit 8.83 M
Operating Expenses 60.7 M
Operating Income -51.9 M
Other Expenses 12.9 M
Net Income -64.8 M
30m30m20m20m10m10m00(10m)(10m)(20m)(20m)(30m)(30m)(40m)(40m)(50m)(50m)(60m)(60m)(70m)(70m)22m(13m)9m(61m)(52m)(13m)(65m)RevenueRevenueCost Of RevenueCost Of RevenueGross ProfitGross ProfitOperating ExpensesOperating ExpensesOperating IncomeOperating IncomeOther ExpensesOther ExpensesNet IncomeNet Income
RATIOS
40.61% GROSS MARGIN
40.61%
-238.73% OPERATING MARGIN
-238.73%
-288.48% NET MARGIN
-288.48%
-30.40% ROE
-30.40%
-24.68% ROA
-24.68%
-23.90% ROIC
-23.90%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Prenetics Global Limited
image
10m10m5m5m00(5m)(5m)(10m)(10m)(15m)(15m)20202020Jul '20Jul '2020212021Jul '21Jul '2120222022Jul '22Jul '2220232023Jul '23Jul '2320242024
Net Income -64.8 M
Depreciation & Amortization 7.79 M
Capital Expenditures -912 K
Stock-Based Compensation 10.6 M
Change in Working Capital 24.2 M
Others 2.73 M
Free Cash Flow -14.7 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets Prenetics Global Limited
image
PRE has no price targets from Wall Street.
4. DIVIDEND ANALYSIS
0.00% DIVIDEND YIELD
0.7 USD DIVIDEND PER SHARE
Q1
Q2
Q3
Q4
3.03.02.52.52.02.01.51.51.01.00.50.50.00.00.70.70.70.70.72.800.702015201520162016
Download SVG
Download PNG
Download CSV
5. COMPETITION
slide 2 of 12
6. Ownership
Insider Ownership Prenetics Global Limited
image
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
0 USD 0
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
7. News
Prenetics' IM8 Health Expands Scientific Advisory Board, Reinforcing Commitment to Set New Standards in Supplements Market Adds Renowned Clinical Experts Dr. Jeremy London and Dr. Amy Shah to Existing Team from Mayo Clinic, Cedars-Sinai, NASA and Yale University globenewswire.com - 1 month ago
Prenetics Announces Fourth Quarter and Full Year 2024 Financial Results, Provides 2025 Guidance Revenue grew 93.5% to $10.5 million in the fourth quarter and 40.9% year-over-year to $30.6 million in 2024 globenewswire.com - 2 months ago
NYSE CONTENT ADVISORY: PRE-MARKET UPDATE + TARGET & BEST BUY HIGHLIGHT RETAIL EARNINGS NEW YORK , March 4, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) is proud to offer a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins. prnewswire.com - 2 months ago
NYSE CONTENT ADVISORY: PRE-MARKET UPDATE FOR FEBRUARY 26TH NEW YORK , Feb. 26, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) is proud to offer a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins. prnewswire.com - 2 months ago
NYSE CONTENT ADVISORY: PRE-MARKET UPDATE FOR FEBRUARY 24TH NEW YORK , Feb. 24, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) is proud to offer a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins. prnewswire.com - 2 months ago
NYSE CONTENT ADVISORY: PRE-MARKET UPDATE FOR FEBRUARY 20TH + WALMART REPORTS EARNINGS NEW YORK , Feb. 20, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) is proud to offer a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins. prnewswire.com - 2 months ago
NYSE CONTENT ADVISORY: PRE-MARKET UPDATE FOR FEBRUARY 19TH + NIKE ANNOUNCES COLLABORATION WITH SKIMS NEW YORK , Feb. 19, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) is proud to offer a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins. prnewswire.com - 2 months ago
NYSE CONTENT ADVISORY: PRE-MARKET UPDATE FOR FEBRUARY 14th + KARMAN POPS DOUBLE DIGIT IPO NEW YORK , Feb. 14, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) is proud to offer a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins. prnewswire.com - 2 months ago
Nasdaq-Listed Prenetics Announces Genomics-Based Partnership with Humanity Protocol and Launches Crypto Strategic Reserve CHARLOTTE, N.C., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE), a leading genomics and consumer healthcare company, today announced a groundbreaking genomics-based partnership with Humanity Protocol, a decentralized identity verification company. This collaboration leverages Prenetics' advanced genetic testing capabilities to underpin decentralized identity verification. globenewswire.com - 2 months ago
Prenetics' IM8 Achieves Prestigious NSF Certified for Sport® for Daily Ultimate Essentials – David Beckham Co-Founded Premium Supplements Brand Sets the Standard for Science-Backed Excellence – Tested for 280+ banned substances, trusted by global athletes in WADA, NFL, NBA, MLB, PGA and more – IM8 is available at IM8health.com , shipping to 31 countries and regions CHARLOTTE, N.C., Jan. 15, 2025 (GLOBE NEWSWIRE) -- Prenetics' IM8, a premium supplements brand co-founded by David Beckham, announces its flagship product, Daily Ultimate Essentials, has been certified to NSF Certified for Sport®, a globally recognized standard for supplement safety, quality, and transparency. globenewswire.com - 3 months ago
NYSE CONTENT ADVISORY: PRE MARKET UPDATE AND WEEKLY RECAP DECEMBER 20, 2024 NEW YORK , Dec. 20, 2024 /PRNewswire/ -- The New York Stock Exchange (NYSE) is proud to offer a new daily pre-market update and additional content directly from the iconic NYSE Trading Floor.  Access today's NYSE Pre-market update as well as a Weekly Recap for market insights and other content before trading begins. prnewswire.com - 4 months ago
NYSE CONTENT ADVISORY: PRE MARKET UPDATE AND EOY VIDEO DECEMBER 19, 2024 NEW YORK , Dec. 19, 2024 /PRNewswire/ -- The New York Stock Exchange (NYSE) is proud to offer a new daily pre-market update and additional content directly from the iconic NYSE Trading Floor.  Access today's NYSE Pre-market update for market insights and other content before trading begins. prnewswire.com - 4 months ago
8. Profile Summary

Prenetics Global Limited PRE

image
COUNTRY HK
INDUSTRY Medical - Diagnostics & Research
MARKET CAP $ 55 M
Dividend Yield 0.00%
Description Prenetics Global Limited, an investment holding company, operates as a diagnostics and genetic testing company. Its products include CircleDNA, a consumer genetic testing product; and Circle HealthPod, a rapid detection health monitoring system that allows users to take COVID-19 tests at point-of-care or at home utilizing the nucleic acid amplification test. The company's products also comprise ColoClear, a non-invasive FIT-DNA colorectal cancer screening test; Circle SnapShot, an off-the-shelf at-home blood test; Circle Medical, a diagnostic testing product; and Circle One and F1x/Fem. Prenetics Global Limited was founded in 2014 and is headquartered in Quarry Bay, Hong Kong.
Contact Unit 701-706, K11 Atelier King’s Road, Quarry Bay, https://www.prenetics.com
IPO Date July 16, 2021
Employees 320
Officers Mr. Hoi Chun Lo Chief Financial Officer Dr. Chi Hung Tzang Ph.D. Co-Founder & Chief Scientific Officer Ms. Samantha Kwok Chief of Staff to Group Chief Executive Officer & Vice President of People & Operations Mr. Sheng Wu Yeung Co-Founder, Chairperson & Chief Executive Officer